Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 INDUSTRY INSIGHTS:
6 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, REGULATIONS
6.1 EUROPEAN UNION REGULATORY SCENARIO
6.2 U.S. REGULATORY SCENARIO
6.3 JAPAN REGULATORY SCENARIO
6.4 CHINA REGULATORY SCENARIO
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES
7.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS
7.1.3 GROWING DEMAND FOR CHIMERIC GENES
7.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH
7.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS
7.2 RESTRAINTS
7.2.1 HIGH COST OF TRANSFECTION PRODUCTS
7.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS
7.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE
7.3 OPPORTUNITIES
7.3.1 EXPLORATION OF EMERGING MARKET
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.3.3 SURGING LEVEL OF INVESTMENT
7.4 CHALLENGES
7.4.1 LONG APPROVAL PROCEDURE
7.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS-ASSOCIATED TRANSFECTION
7.4.3 LACK OF TRAINED PROFESSIONALS
8 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS
8.1 OVERVIEW
8.2 REAGENTS & KITS
8.3 INSTRUMENTS
9 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE
9.1 OVERVIEW
9.2 RESEARCH
9.3 PRECLINICAL
9.4 CLINICAL PHASES
9.5 COMMERCIAL
10 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE
10.1 OVERVIEW
10.2 TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT
10.3 STABLE TRANSECTION REAGENTS AND EQUIPMENT
11 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY METHODS
11.1 OVERVIEW
11.2 NON-VIRAL METHODS
11.3 VIRAL METHODS
12 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE
12.1 OVERVIEW
12.2 PLASMID DNA
12.3 SMALL INTERFERING RNA (SIRNA)
12.4 PROTEINS
12.5 DNA OLIGONUCLEOTIDES
12.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS)
12.7 OTHERS
13 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM
13.1 OVERVIEW
13.2 MAMMALIAN CELLS
13.3 PLANTS
13.4 FUNGI
13.5 VIRUS
13.6 BACTERIA
14 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 IN VITRO APPLICATION
14.2.1 IN VIVO APPLICATION
14.2.2 BIOPRODUCTION
14.2.3 OTHERS
14.2.4 SYNTHETIC BIOLOGY
14.2.5 AGRICULTURE
14.2.6 OTHERS
15 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER
15.1 OVERVIEW
15.2 BIOPHARMA
15.3 CROS
15.4 CMOS/CDMOS
15.5 ACADEMIA
15.6 HOSPITALS
15.7 CLINICAL LABS
15.8 OTHERS
16 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.4 OTHERS
17 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION
17.1 MIDDLE EAST AND AFRICA
17.1.1 SOUTH AFRICA
17.1.2 SAUDI ARABIA
17.1.3 U.A.E.
17.1.4 EGYPT
17.1.5 ISRAEL
17.1.6 REST OF MIDDLE EAST AND AFRICA
18 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 THERMO FISHER SCIENTIFIC INC.
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENT
20.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENT
20.3 PROMEGA CORPORATION
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 TAKARA BIO INC.
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENT
20.5 BIO-RAD LABORATORIES, INC.
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANANLYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENT
20.6 ALTOGEN BIOSYSTEMS
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
20.8.1 COMPANY SNAPSHOT
20.8.2 REVENUE ANALYSIS
20.8.3 PRODUCT PORTFOLIO
20.8.4 RECENT DEVELOPMENT
20.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT
20.1 CYTIVA
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENT
20.11 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
20.11.1 COMPANY SNAPSHOT
20.11.2 REVENUE ANANLYSIS
20.11.3 PRODUCT PORTFOLIO
20.11.4 RECENT DEVELOPMENT
20.12 GENLANTIS INC.
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 GENO TECHNOLOGY INC., USA
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 GINKGO BIOWORKS
20.14.1 COMPANY SNAPSHOT
20.14.2 PRODUCT PORTFOLIO
20.14.3 RECENT DEVELOPMENTS
20.15 LONZA
20.15.1 COMPANY SNAPSHOT
20.15.2 REVENUE ANANLYSIS
20.15.3 PRODUCT PORTFOLIO
20.15.4 RECENT DEVELOPMENT
20.16 MAXCYTE, INC.
20.16.1 COMPANY SNAPSHOT
20.16.2 REVENUE ANALYSIS
20.16.3 PRODUCT PORTFOLIO
20.16.4 RECENT DEVELOPMENT
20.17 MERCK KGAA
20.17.1 COMPANY SNAPSHOT
20.17.2 REVENUE ANALYSIS
20.17.3 PRODUCT PORTFOLIO
20.17.4 RECENT DEVELOPMENT
20.18 MIRUS BIO LLC.
20.18.1 COMPANY SNAPSHOT
20.18.2 PRODUCT PORTFOLIO
20.18.3 RECENT DEVELOPMENT
20.19 ORIGENE TECHNOLOGIES, INC.
20.19.1 COMPANY SNAPSHOT
20.19.2 PRODUCT PORTFOLIO
20.19.3 RECENT DEVELOPMENT
20.2 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
20.20.1 COMPANY SNAPSHOT
20.20.2 REVENUE ANALYSIS
20.20.3 PRODUCT PORTFOLIO
20.20.4 RECENT DEVELOPMENT
20.21 POLYPLUS TRANSFECTION
20.21.1 COMPANY SNAPSHOT
20.21.2 PRODUCT PORTFOLIO
20.21.3 RECENT DEVELOPMENT
20.22 R&D SYSTEMS, INC.
20.22.1 COMPANY SNAPSHOT
20.22.2 PRODUCT PORTFOLIO
20.22.3 RECENT DEVELOPMENT
20.23 SBS GENETECH
20.23.1 COMPANY SNAPSHOT
20.23.2 PRODUCT PORTFOLIO
20.23.3 RECENT DEVELOPMENT
20.24 SIGNAGEN LABORATORIES
20.24.1 COMPANY SNAPSHOT
20.24.2 PRODUCT PORTFOLIO
20.24.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS, 2021-2030 (USD THOUSAND)
TABLE 2 MIDDLE EAST & AFRICA REAGENT AND KITS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 3 MIDDLE EAST & AFRICA INSTRUMENTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE, 2021-2030 (USD THOUSAND)
TABLE 5 MIDDLE EAST & AFRICA RESEARCH IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 6 MIDDLE EAST & AFRICA PRECLINICAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 MIDDLE EAST & AFRICA CLINICAL PHASES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 MIDDLE EAST & AFRICA COMMERCIAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 9 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 10 MIDDLE EAST & AFRICA TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 MIDDLE EAST & AFRICA STABLE TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2021-2030 (USD THOUSAND)
TABLE 13 MIDDLE EAST & AFRICA NON-VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 MIDDLE EAST & AFRICA VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE, 2021-2030 (USD THOUSAND)
TABLE 16 MIDDLE EAST & AFRICA PLASMID DNA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 MIDDLE EAST & AFRICA SMALL INTERFERING RNA (SIRNA) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 18 MIDDLE EAST & AFRICA PROTEINS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 MIDDLE EAST & AFRICA DNA OLIGONUCLEOTIDES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 MIDDLE EAST & AFRICA RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 MIDDLE EAST & AFRICA OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM, 2021-2030 (USD THOUSAND)
TABLE 23 MIDDLE EAST & AFRICA MAMMALIAN CELLS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 MIDDLE EAST & AFRICA PLANTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 MIDDLE EAST & AFRICA FUNGI IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 MIDDLE EAST & AFRICA VIRUS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 MIDDLE EAST & AFRICA BACTERIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET , BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 29 MIDDLE EAST & AFRICA IN VITRO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 30 MIDDLE EAST & AFRICA IN VIVO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 31 MIDDLE EAST & AFRICA BIOPRODUCTION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 MIDDLE EAST & AFRICA OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 MIDDLE EAST & AFRICA APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY INDUSTRY, 2021-2030 (USD THOUSAND)
TABLE 34 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 35 MIDDLE EAST & AFRICA BIOPHARMA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 36 MIDDLE EAST & AFRICA CROS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 MIDDLE EAST & AFRICA CMOS/CDMOS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 38 MIDDLE EAST & AFRICA ACADEMIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 39 MIDDLE EAST & AFRICA HOSPITALS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 40 MIDDLE EAST & AFRICA CLINICAL LABS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 41 MIDDLE EAST & AFRICA OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 42 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 43 MIDDLE EAST & AFRICA DIRECT TENDER IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 44 MIDDLE EAST & AFRICA RETAIL SALES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 45 MIDDLE EAST & AFRICA OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST & AFRICA TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2022 TO 2030
FIGURE 13 THE TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN 2022 & 2030
FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET
FIGURE 16 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023
FIGURE 17 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023-2030 (USD THOUSAND)
FIGURE 18 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, CAGR (2023-2030)
FIGURE 19 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 20 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023
FIGURE 21 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023-2030 (USD THOUSAND)
FIGURE 22 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, CAGR (2023-2030)
FIGURE 23 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023
FIGURE 25 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023-2030 (USD THOUSAND)
FIGURE 26 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 27 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2022
FIGURE 29 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2023-2030 (USD THOUSAND)
FIGURE 30 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, CAGR (2023-2030)
FIGURE 31 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, LIFELINE CURVE
FIGURE 32 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2022
FIGURE 33 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2023-2030 (USD THOUSAND)
FIGURE 34 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, CAGR (2023-2030)
FIGURE 35 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, LIFELINE CURVE
FIGURE 36 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2022
FIGURE 37 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2023-2030 (USD THOUSAND)
FIGURE 38 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, CAGR (2023-2030)
FIGURE 39 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, LIFELINE CURVE
FIGURE 40 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2022
FIGURE 41 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 42 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, CAGR (2023-2030)
FIGURE 43 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, LIFELINE CURVE
FIGURE 44 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY END USER, 2022
FIGURE 45 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 46 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, CAGR (2023-2030)
FIGURE 47 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, LIFELINE CURVE
FIGURE 48 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 49 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 50 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 51 MIDDLE EAST & AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 52 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022)
FIGURE 53 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022)
FIGURE 54 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 55 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022 & 2030)
FIGURE 56 MIDDLE EAST AND AFRICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030)
FIGURE 57 MIDDLE EAST & AFRICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%)
